JCR Pharmaceuticals Co., Ltd. (TYO:4552)

Japan flag Japan · Delayed Price · Currency is JPY
682.00
+4.00 (0.59%)
Jan 22, 2026, 3:30 PM JST
26.77%
Market Cap82.71B
Revenue (ttm)37.78B
Net Income (ttm)-2.36B
Shares Out121.98M
EPS (ttm)-19.29
PE Ration/a
Forward PE38.57
Dividend20.00 (2.88%)
Ex-Dividend DateMar 30, 2026
Volume259,600
Average Volume566,085
Open685.00
Previous Close678.00
Day's Range681.00 - 689.00
52-Week Range386.00 - 824.00
Beta-0.06
RSI42.42
Earnings DateJan 28, 2026

About JCR Pharmaceuticals

JCR Pharmaceuticals Co., Ltd., together with its subsidiaries, engages in the research, development, manufacture, import and export, and sale of pharmaceutical products, regenerative medicines, and drug substances in Japan. It offers various therapeutic products, including GROWJECT used for the treatment of growth hormone deficiency and short stature; IZCARGO to treat Mucopolysaccharidosis type II; Agalsidase Beta BS I.V. Infusion used for the treatment of Fabry disease; and TEMCELL HS Inj used to treat acute graft-versus-host disease. The comp... [Read more]

Sector Healthcare
Founded 1975
Employees 987
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 4552
Full Company Profile

Financial Performance

Financial Statements